Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127195501 | 12719550 | 1 | I | 20160831 | 20160907 | 20160907 | EXP | US-AMGEN-USASP2016118427 | AMGEN | 0.00 | F | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127195501 | 12719550 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK UNK, UNK | U | 125031 | UNKNOWN FORMULATION | ||||||||
| 127195501 | 12719550 | 2 | C | AROMASIN | EXEMESTANE | 1 | UNK | 0 | |||||||||||
| 127195501 | 12719550 | 3 | C | AROMASIN | EXEMESTANE | 1 | 0 | ||||||||||||
| 127195501 | 12719550 | 4 | C | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127195501 | 12719550 | 5 | C | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127195501 | 12719550 | 6 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | 0 | |||||||||||
| 127195501 | 12719550 | 7 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 127195501 | 12719550 | 8 | C | TAXOL | PACLITAXEL | 1 | UNK | 0 | |||||||||||
| 127195501 | 12719550 | 9 | C | TAXOL | PACLITAXEL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127195501 | 12719550 | 1 | Product used for unknown indication |
| 127195501 | 12719550 | 2 | Invasive ductal breast carcinoma |
| 127195501 | 12719550 | 3 | Human epidermal growth factor receptor negative |
| 127195501 | 12719550 | 4 | Invasive ductal breast carcinoma |
| 127195501 | 12719550 | 5 | Human epidermal growth factor receptor negative |
| 127195501 | 12719550 | 6 | Invasive ductal breast carcinoma |
| 127195501 | 12719550 | 7 | Human epidermal growth factor receptor negative |
| 127195501 | 12719550 | 8 | Invasive ductal breast carcinoma |
| 127195501 | 12719550 | 9 | Human epidermal growth factor receptor negative |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127195501 | 12719550 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127195501 | 12719550 | Bone pain | |
| 127195501 | 12719550 | Headache | |
| 127195501 | 12719550 | Spinal fusion surgery |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127195501 | 12719550 | 4 | 20160802 | 0 | ||
| 127195501 | 12719550 | 6 | 20160802 | 0 | ||
| 127195501 | 12719550 | 8 | 20160802 | 0 |